跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 251 条关于
“FR𝛼”
全部
251
临床试验
94
药物
144
机构
0
资讯
13
去年
Elahere Demonstrates Significant Survival Benefit in Phase III MIRASOL Trial for Platinum-Resistant Ovarian Cancer
去年
Sutro Biopharma Reports Promising Results for Luvelta in Platinum-Resistant Ovarian Cancer Trial
去年
Top Oncology Healthcare Trends of 2024: Prior Authorization, PBM Reform, and Patient Navigation Lead Discussion
去年
ELAHERE Shows 32% Reduction in Death Risk for Platinum-Resistant Ovarian Cancer in Final MIRASOL Trial Analysis
去年
Mirvetuximab Soravtansine Gains Global Approvals for FRα-Positive Platinum-Resistant Ovarian Cancer
2年前
CHMP Recommends Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer
去年
Ultimovacs ASA Provides Update on Clinical Trials and Financial Strategy
去年
BerGenBio's AXL Inhibitor Shows Promise in STK11-Mutated Lung Cancer, Faces Leadership Transition
去年
BerGenBio's AXL Inhibitor Receives FDA Fast Track for STK11-Mutated Cancers Amidst Leadership Transition
2年前
FDA Clears IND Application for Zymeworks' Novel FRα-Targeted ADC, ZW191
第 1 页,共 2 页
上一页
下一页